Fresenius Medical Care AG & Co. KGaA (FMS) Stock Price, News & Analysis

Company Overview

Fresenius Medical Care AG & Co. KGaA is a global provider of products and services for individuals with chronic kidney failure. The company designs, manufactures and distributes a comprehensive range of dialysis machines, dialyzers and related disposables, as well as water treatment systems and monitoring equipment. In addition to its core product portfolio, Fresenius Medical Care offers clinical services through a network of outpatient dialysis centers, delivering both in-center and home-based hemodialysis and peritoneal dialysis treatments.

Beyond its clinical operations, the company maintains an extensive research and development program focused on advancing therapies for renal and associated cardiovascular complications. Its activities include innovations in biocompatible membranes, online hemodiafiltration and digital health solutions aimed at improving patient outcomes and operational efficiency. Support services range from patient education and nutritional counseling to laboratory testing and telemedicine platforms that facilitate remote monitoring and care coordination.

Fresenius Medical Care serves patients in more than 40 countries across Europe, North America, Asia-Pacific, Latin America and the Middle East & Africa. Its geographic footprint is supported by manufacturing facilities, logistics hubs and R&D centers strategically located to meet regional regulatory requirements and local market needs. Through partnerships with hospitals, healthcare providers and payers, the company seeks to expand access to renal care in both mature and emerging markets.

Established in 1996 through the merger of established renal care businesses, Fresenius Medical Care has grown into the largest integrated kidney care company worldwide. Headquartered in Bad Homburg, Germany, it operates under German corporate governance with a Management Board and a Supervisory Board. The executive team is responsible for setting strategic priorities around patient-centric innovation, quality standards and sustainable growth, reflecting the company’s commitment to advancing renal care globally.

Key Stats

• Today's Range: $27.29 to $27.49
• 50-Day Range: $25.04 to $29.88
• 52-Week Range: $17.93 to $30.46
• Volume: 163,259 shs
• Average Volume: 333,599 shs
• Market Capitalization: N/A
• P/E Ratio: 24.46
• Dividend Yield: 2.08%
• Price Target: $27.80
• Consensus Rating: Hold

Fresenius Medical Care AG & Co. KGaA Stock Analysis - MarketRank™

Fresenius Medical Care AG & Co. KGaA scored higher than 58% of companies evaluated by MarketBeat, and ranked 427th out of 920 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Hold

Consensus Rating

Fresenius Medical Care AG & Co. KGaA has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 2 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Fresenius Medical Care AG & Co. KGaA has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 5.0 / 5
• Proj. Earnings Growth: 27.15%

Earnings Growth

Earnings for Fresenius Medical Care AG & Co. KGaA are expected to grow by 27.15% in the coming year, from $1.51 to $1.92 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Fresenius Medical Care AG & Co. KGaA is 24.45, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.67.

Price to Earnings Ratio vs. Sector

The P/E ratio of Fresenius Medical Care AG & Co. KGaA is 24.45, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.18.

Price to Earnings Growth Ratio

Fresenius Medical Care AG & Co. KGaA has a PEG Ratio of 0.65. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

Fresenius Medical Care AG & Co. KGaA has a P/B Ratio of 0.94. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Fresenius Medical Care AG & Co. KGaA has a short interest ratio ("days to cover") of 5.

Change versus previous month

Short interest in Fresenius Medical Care AG & Co. KGaA has recently increased by 36.26%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Fresenius Medical Care AG & Co. KGaA pays a meaningful dividend of 2.07%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Fresenius Medical Care AG & Co. KGaA does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Fresenius Medical Care AG & Co. KGaA is 50.89%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Fresenius Medical Care AG & Co. KGaA will have a dividend payout ratio of 29.69% next year. This indicates that Fresenius Medical Care AG & Co. KGaA will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Fresenius Medical Care AG & Co. KGaA has a short interest ratio ("days to cover") of 5.

Change versus previous month

Short interest in Fresenius Medical Care AG & Co. KGaA has recently increased by 36.26%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.6 / 5
• News Sentiment: N/A

News Sentiment

Fresenius Medical Care AG & Co. KGaA has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Fresenius Medical Care AG & Co. KGaA this week, compared to 3 articles on an average week.

Search Interest

2 people have searched for FMS on MarketBeat in the last 30 days.

MarketBeat Follows

Only 1 people have added Fresenius Medical Care AG & Co. KGaA to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Fresenius Medical Care AG & Co. KGaA insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 8.37% of the stock of Fresenius Medical Care AG & Co. KGaA is held by institutions.

FMS Stock Analysis - Frequently Asked Questions

How have FMS shares performed this year?

Fresenius Medical Care AG & Co. KGaA's stock was trading at $22.64 at the beginning of 2025. Since then, FMS stock has increased by 21.0% and is now trading at $27.4050.

How were Fresenius Medical Care AG & Co. KGaA's earnings last quarter?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) issued its quarterly earnings data on Tuesday, May, 6th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.01. The company had revenue of $5.54 billion for the quarter, compared to analysts' expectations of $4.71 billion. Fresenius Medical Care AG & Co. KGaA had a trailing twelve-month return on equity of 6.25% and a net margin of 3.18%.
Read the conference call transcript.

Does Fresenius Medical Care AG & Co. KGaA have any subsidiaries?

Fresenius Medical Care AG & Co. KGaA subsidiaries include NxStage Medical.

Who are Fresenius Medical Care AG & Co. KGaA's major shareholders?

Fresenius Medical Care AG & Co. KGaA's top institutional investors include Balefire LLC (0.01%) and Veracity Capital LLC.

How do I buy shares of Fresenius Medical Care AG & Co. KGaA?

Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Fresenius Medical Care AG & Co. KGaA investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Energy Transfer (ET), AbbVie (ABBV), GE Aerospace (GE) and Adobe (ADBE).

Company Calendar

• Last Earnings: 5/06/2025
• Record date for 6/6 Dividend: 5/23/2025
• Ex-Dividend for 6/6 Dividend: 5/23/2025
• Dividend Payable: 6/06/2025
• Today: 7/10/2025
• Next Earnings (Estimated): 7/29/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Healthcare
• Current Symbol: NYSE:FMS
• CIK: 1333141
• Web: www.freseniusmedicalcare.com
• Phone: (496) 172-6090
• Fax: 49-6172-609-2301
• Employees: 1,384
• Year Founded: 1912

Price Target and Rating

• Average Price Target for Fresenius Medical Care AG & Co. KGaA: $27.80
• High Price Target: $30.00
• Low Price Target: $25.60
• Potential Upside/Downside: +1.6%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.12
• Trailing P/E Ratio: 24.42
• Forward P/E Ratio: 18.12
• P/E Growth: 0.65
• Net Income: $582.08 million
• Net Margins: 3.18%
• Pretax Margin: 5.91%
• Return on Equity: 6.25%
• Return on Assets: 2.88%

Debt

• Debt-to-Equity Ratio: 0.40
• Current Ratio: 1.46
• Quick Ratio: 1.08

Sales & Book Value

• Annual Sales: $20.63 billion
• Price / Sales: N/A
• Cash Flow: $4.84 per share
• Price / Cash Flow: 5.65
• Book Value: $29.08 per share
• Price / Book: 0.94

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Optionable
• Beta: 0.87